205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.89%
Revenue growth above 1.5x NXPI's 3.21%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
14.06%
Gross profit growth above 1.5x NXPI's 0.13%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
32.73%
Positive EBIT growth while NXPI is negative. John Neff might see a substantial edge in operational management.
32.73%
Positive operating income growth while NXPI is negative. John Neff might view this as a competitive edge in operations.
308.03%
Positive net income growth while NXPI is negative. John Neff might see a big relative performance advantage.
316.22%
Positive EPS growth while NXPI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
316.67%
Positive diluted EPS growth while NXPI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-2.02%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.98%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.07%
Dividend reduction while NXPI stands at 0.12%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
14.72%
OCF growth under 50% of NXPI's 37.88%. Michael Burry might suspect questionable revenue recognition or rising costs.
77.85%
FCF growth 75-90% of NXPI's 94.26%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
50.46%
10Y revenue/share CAGR at 50-75% of NXPI's 79.10%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
109.30%
5Y revenue/share CAGR 1.25-1.5x NXPI's 77.31%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
75.93%
Positive 3Y CAGR while NXPI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
278.11%
10Y OCF/share CAGR above 1.5x NXPI's 104.58%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
25.75%
Below 50% of NXPI's 107.18%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
88.16%
Positive 3Y OCF/share CAGR while NXPI is negative. John Neff might see a big short-term edge in operational efficiency.
2966.45%
Net income/share CAGR above 1.5x NXPI's 36.73% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
1497.30%
5Y net income/share CAGR above 1.5x NXPI's 328.95%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
2095.75%
Positive short-term CAGR while NXPI is negative. John Neff would see a clear advantage in near-term profit trajectory.
191.78%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
16.42%
5Y equity/share CAGR at 75-90% of NXPI's 18.89%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
30.08%
3Y equity/share CAGR at 50-75% of NXPI's 42.98%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
42.42%
Dividend/share CAGR of 42.42% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
46.49%
Below 50% of NXPI's 169.49%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
41.39%
3Y dividend/share CAGR above 1.5x NXPI's 20.43%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
7.29%
AR growth well above NXPI's 1.04%. Michael Burry fears inflated revenue or higher default risk in the near future.
7.14%
Inventory growth well above NXPI's 0.47%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
13.46%
Asset growth above 1.5x NXPI's 0.28%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
16.14%
BV/share growth above 1.5x NXPI's 3.20%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-86.48%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
0.56%
R&D dropping or stable vs. NXPI's 4.75%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-0.71%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.